Frontier Medicines

Director, Clinical Operations

Frontier Medicines  •  $195k - $245k/yr  •  Boston, MA (Onsite)  •  3 months ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

What’s in it for you?

Frontier Medicines is seeking a Director, Clinical Operations Program Lead to drive the operational strategy and execution of a global oncology program as it advances through clinical development. This role will serve as the operational leader for the program, translating clinical and business strategy into high-quality, on-time study delivery across regions and partners.

Working in close partnership with cross-functional leaders and global CROs, the Director will oversee program-level planning, risk mitigation, vendor management, and budget accountability while ensuring compliance with global regulatory standards. The ideal candidate brings deep oncology experience, strong global study oversight, and the ability to influence stakeholders, anticipate challenges, and deliver results in a dynamic biotech environment.

Requirements

What will you be doing?

• Develop clinical operational strategy and ensure clinical research studies are executed with quality and efficiency, on-time, within budget, and to meet company objectives

• Translate program strategy into operational execution by developing the clinical operations plan (or strategy) and connecting science with the business, operations, and patients

• Identify and evaluate risks and mitigations at program level to achieve the program strategy.

• Interact with and influence management and cross-functional team members to achieve program objectives and represent Clinical Operations at cross-functional meetings

• Review and provide clinical operations content to clinical and regulatory documents

• Manage overall external budget management

• Execute clinical programs in compliance with quality standards (ICH/GCP, Global Regulations, and company policies and procedures)

• Drive activities and find solutions to deliver on the program

Traits we believe make a strong candidate:

• Bachelor’s degree or work experience equivalent is required, preferably in a scientific field.

• 10+ years of Biotech/Pharma clinical research related experience

• Strong vendor management and oversight experience

• Strong experience in oncology

• Proven ability in working on a global team in the management and completion of multiple, complex clinical studies

• Competent in application of standard business procedures (SOPs, ICH, Global Regulations, Ethics and Compliance)

• Integral participation in initiatives or advancement strategies for clinical operations

• Experience in successful study initiation through study completion and in multiple phases of studies (Phases 1-3)

• Strong communication and stakeholder management skills.

• Legally authorized to work in the United States.

Benefits

  • Health Care Plan (Medical, Dental & Vision)
  • Retirement Plan (401k, IRA)
  • Life Insurance (Basic, Voluntary & AD&D)
  • Paid Time Off (Vacation, Sick & Public Holidays)
  • Family Leave (Maternity, Paternity)
  • Short Term & Long Term Disability
  • Training & Development
  • Free Food & Snacks
  • Wellness Resources
  • Stock Option Plan

At Frontier, we strive to build a diverse and equitable workplace. The salary range for this role is $195,000 - $245,000. Compensation for the role will depend on a number of factors, including candidates' qualifications, skills, competencies and experience. Frontier offers a competitive total rewards package which includes healthcare coverage, 401k and a broad range of other benefits.

This compensation and benefits information is based on Frontier's knowledge as of the date of publication, and may be modified in the future.

Frontier Medicines

About Frontier Medicines

Frontier Medicines, located in South San Francisco, CA and Boston, MA, is a precision medicine company that has pioneered a powerful discovery and development platform designed to generate medicines against disease-causing proteins previously considered undruggable. We are deploying our technologies in chemoproteomics, covalent drug discovery, and machine learning to develop a pipeline of groundbreaking medicines against the most important drivers of disease. Our lead program targets both the activated and inactive forms of KRAS G12C, a validated driver in a number of cancers that until recently has been undruggable. Our pipeline embodies our vision of bolding advancing science to defeat disease, starting with cancer.

Industry
Biotech & Life Sciences
Company Size
51-200 employees
Headquarters
South San Francisco, CA
Year Founded
2018
Social Media